Developing World Bioethics, published by WILEY, is an esteemed journal dedicated to the exploration and advancement of ethical issues in health and healthcare within developing countries. Since its inception in 2001, this journal has become a critical platform for disseminating scholarly research and discourse that address complex bioethical challenges in varied socio-economic contexts. With an impressive Q2 ranking in multiple categories, including Health Policy and Issues, Ethics and Legal Aspects, it stands out as a vital resource among its peers, boasting significant Scopus rankings that highlight its influence and contribution to the fields of health and social sciences. The journal is committed to fostering interdisciplinary dialogue and insight, making it an invaluable asset for researchers, professionals, and students keen on bioethics and health policy. While the journal operates on a subscription basis, it provides broad access to its diverse range of articles, ensuring that cutting-edge bioethical perspectives are available to stakeholders worldwide, with a focus on innovative solutions and best practices in healthcare systems globally.

Journal of Practical Ethics is an esteemed open-access journal published by the Oxford Uehiro Centre for Practical Ethics, dedicated to enhancing the discourse surrounding ethical issues in various fields, including healthcare, technology, and social policy. Since its inception in 2013, the journal has fostered a robust academic platform for researchers, professionals, and students to explore and publish innovative ideas and solutions to real-world ethical dilemmas. The journal's commitment to making research freely accessible emphasizes its role in bridging the gap between academic inquiry and practical application, thereby encouraging a broader engagement with ethical considerations across disciplines. As the importance of ethical frameworks continues to grow in an increasingly complex world, the Journal of Practical Ethics stands as a vital resource for those seeking to influence policy and practice through rigorous ethical analysis.

Cuadernos de Bioetica, published by the ASOC ESPANOLA BIOETICA & ETICA MEDICA, is a prominent academic journal dedicated to exploring significant philosophical, ethical, and legal dimensions within the field of bioethics. With an ISSN of 1132-1989 and an E-ISSN of 2386-3773, this journal serves as a vital platform for researchers, professionals, and students in medicine and related disciplines. Since its inception in 2008, it has consistently provided critical analyses and discussions reflecting the evolving landscape of healthcare ethics, contributing notably to the discourse surrounding ethical practices in medicine. Despite its current Q4 ranking in the miscellaneous medicine category, Cuadernos de Bioetica is committed to enhancing its impact and relevance, making it an essential resource for those seeking to navigate the complex ethical challenges in contemporary medical practice. The journal’s reach is underscored by its commitment to fostering open dialogue among diverse stakeholders in the field, encouraging a broad spectrum of contributions to advance knowledge in bioethics.

BioLaw Journal-Rivista di Biodiritto, published by UNIV TRENTO, FAC LAW, stands as a vital interdisciplinary platform in the domains of biolaw, biotechnology, and health policy. With an ISSN of 2284-4503 and a burgeoning reputation, this journal encourages critical discussions surrounding the ethical, legal, and social implications of biotechnological advancements from 2014 to 2024. Ranked Q3 in both Biochemistry and Biotechnology, alongside Q2 rankings in Law and Philosophy, it reflects a growing body of scholarship in these experimental fields. Although currently categorized with varying percentile ranks in the Scopus database, it underlines the journal's commitment to nurturing innovative research and interdisciplinary dialogue. The journal promotes open access principles, although the specific access options should be verified for each article. It serves as an indispensable resource for researchers, professionals, and students engaged in the evolving intersection of law and biotechnology, making it a key player in shaping future discourses in bioethics and policy.

New Bioethics: A Multidisciplinary Journal of Biotechnology and the Body, published by Taylor & Francis Ltd, serves as a pivotal platform for scholarly discourse at the intersection of biotechnology, health policy, and bioethics. With an ISSN of 2050-2877 and E-ISSN 2050-2885, this journal has been contributing to the academic community since its establishment in 2012 and is set to continue through 2024. It holds notable rankings in prestigious fields, including Q4 in Genetics (clinical), Q3 in Health Policy, Q2 in Issues, Ethics and Legal Aspects, and Q3 in Reproductive Medicine as per 2023 quartile indicators. Although no open access model is available, the journal remains an essential resource for those interested in the ethical implications of biotechnological advancements. Its focus on the ethical, legal, and social dimensions of biotechnology is particularly relevant in today's rapidly evolving scientific landscape, making it invaluable for researchers, professionals, and students keen to explore the complexities surrounding the biotechnology and the human condition.

South African Journal of Bioethics and Law, published by HEALTH & MEDICAL PUBLISHING GROUP, stands as a vital academic platform for discussions at the intersection of bioethics and legal studies. With an ISSN of 1999-7639, this journal has embraced an Open Access model since 2008, ensuring global accessibility for researchers, practitioners, and students alike. Based in South Africa, the journal operates from PRIVATE BAG X1, PINELANDS, CAPE TOWN 7430, and features diverse articles that span a multitude of pertinent topics across health professions, law, and public health. It proudly holds a Q3 ranking in Health Professions and Law sectors, affirming its status within the scholarly community. Notably, for the year 2023, it has achieved impressive placements in Scopus ranks, reinforcing its commitment to disseminating high-quality research and fostering dialogues that influence policy and practice in these critical domains. Researchers exploring the intricate ethical and legal dimensions of healthcare will find this journal an indispensable resource.

HEC Forum, an esteemed journal published by Springer, is dedicated to advancing the field of health policy and ethics, bridging critical gaps between healthcare practices and legal frameworks. With the ISSN 0956-2737 and the E-ISSN 1572-8498, this journal has been a pivotal platform since its inception in 1989, collaborating with scholars and practitioners up to the year 2024. Recognized within the Q3 quartile of several categories—including Health Policy and Issues, Ethics and Legal Aspects—HEC Forum holds a significant position in scholarly circles, showcasing rigorous research and discussions relevant to today’s health care challenges. The journal's Scopus rankings highlight its impact, positioned favorably in the realms of Nursing and Health Policy. Although it does not offer open access, HEC Forum remains a critical resource for researchers, professionals, and students seeking to deepen their understanding of health ethics and policy implications in a rapidly evolving landscape.

JOURNAL OF MEDICAL ETHICS, published by the esteemed BMJ PUBLISHING GROUP, is a leading journal that has been pivotal in advancing the discourse on ethical issues in healthcare since its inception in 1975. This UK-based journal, with an ISSN of 0306-6800 and an E-ISSN of 1473-4257, is well-regarded for its high-quality, peer-reviewed articles that delve into the complex moral dimensions surrounding medical practices, health policies, and social sciences. With a commendable impact, JOURNAL OF MEDICAL ETHICS has achieved Q1 quartile rankings across multiple categories, including Arts and Humanities and Health Policy in 2023, reflecting its significant influence and relevance in the field—ranked #23 of 552 in Arts and Humanities (Miscellaneous) with a 95th percentile, and #26 in Health Policy with a 91st percentile. Researchers, professionals, and students alike can benefit from the journal's commitment to fostering a deeper understanding of ethical considerations vital to the medical community, although it currently does not offer open access options. The journal's comprehensive examination of issues, ethics, and legal aspects continues to make it an essential resource for those dedicated to shaping the ethical landscape of healthcare.

AMERICAN JOURNAL OF LAW & MEDICINE is a prestigious interdisciplinary journal published by Cambridge University Press that bridges the critical intersection of legal and medical scholarship. Since its inception in 1975, this journal has fostered scholarly dialogue surrounding complex legal issues affecting health care and medical ethics, significantly contributing to the fields of law and the social sciences. With its current impact factor highlights showcasing a Q2 ranking in Law and Q3 in Health (Social Science), along with a solid readership base, the journal appeals to researchers, legal professionals, and students alike, offering a platform for impactful research and case studies. Although it does not currently provide Open Access options, the journal continues to prioritize rigorous peer-reviewed content, ensuring that essential discussions on law and medicine remain accessible to its readership. By engaging with contemporary legal and medical issues, the AMERICAN JOURNAL OF LAW & MEDICINE plays a vital role in advancing knowledge and shaping practices within these dynamic fields.

Asian Bioethics Review, published by SPRINGER, is a premier journal indexed with ISSN 1793-8759 and E-ISSN 1793-9453, dedicated to advancing discourse in the interdisciplinary field of bioethics across Asia and beyond. Established in 2015, this esteemed publication has rapidly gained recognition, achieving a Q1 ranking in Philosophy and Q2 in key categories such as Health Policy and Issues, Ethics and Legal Aspects in 2023. With its robust Scopus rankings highlighting its significance across diverse domains—including a remarkable 98th percentile ranking in Philosophy—the journal serves as a vital platform for researchers, ethicists, and policymakers to explore pressing ethical issues and contribute to policy development in health and social sciences. Although not open access, the journal ensures a wide reach through institutional subscriptions, making it an essential resource for students and professionals committed to ethical practices in healthcare. Set in the dynamic backdrop of Singapore, "Asian Bioethics Review" continues to shape the conversation around bioethical practices in the Asian context and globally.